4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034671-25-000009
Chief Executive Officer sold 41,163 shares at $18.86 ($776,429)
- Chief Executive Officer acquired 41,163 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazumdar Claire Chief Executive Officer | 2025-11-24 | Option exercise 10b5-1 | +41,163 | $3.79 | $156,000 | 351,055 | D |
| Mazumdar Claire Chief Executive Officer | 2025-11-24 | Sale 10b5-1 | −41,163 | $18.86 | $776,429 | 309,892 | D |
| Derivatives | |||||||
| Mazumdar Claire Chief Executive Officer | 2025-11-24 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −41,163 | 236,107 | D | ||
| Open-market sales · 41,163 sh · avg $18.86 · $776,429 | |||||||
Loading xslF345X05/wk-form4_1764114037.xml…